1h Free Analyst Time
The in vitro diagnostics (IVD) contract manufacturing market is forecasted to grow by USD 12.96 billion during 2024-2029, accelerating at a CAGR of 13.1% during the forecast period. The report on the in vitro diagnostics (IVD) contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for one-stop-shop ivd contract manufacturing, increasing prevalence of chronic and infectious diseases and rising geriatric population, and high growth potential for market in emerging countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The in vitro diagnostics (IVD) contract manufacturing market is segmented as below:
By Device
- IVD consumables
- IVD equipment/instrument
By Service Type
- Assay development
- Manufacturing
- Others
By Technology
- Immunoassays
- Molecular diagnostics
- Clinical chemistry
- Hematology
- Microbiology
By Geographical Landscape
- Asia
- North America
- Europe
- Rest of World (ROW)
The report on the in vitro diagnostics (IVD) contract manufacturing market covers the following areas:
- In Vitro Diagnostics (IVD) Contract Manufacturing Market sizing
- In Vitro Diagnostics (IVD) Contract Manufacturing Market forecast
- In Vitro Diagnostics (IVD) Contract Manufacturing Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Device
9 Market Segmentation by Service Type
10 Market Segmentation by Technology
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global in vitro diagnostics (IVD) contract manufacturing market: Argonaut Manufacturing Services Inc., Avioq Inc, Bio Techne Corp., CorDx, Genemed Biotechnologies Inc., HDA Technology Inc., HU Group Holdings Inc., Invetech, Jena Bioscience GmbH, JSR Corp., Merck KGaA, More Diagnostics Inc., Neogen Corp., PHC Holdings Corp., Prestige Diagnostics UK Ltd., Seyonic SA, TCS Biosciences Ltd., TE Connectivity Ltd., Thermo Fisher Scientific Inc., and Veracyte Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is leasing of ivd equipment."
According to the report, one of the major drivers for this market is the increasing demand for one-stop-shop ivd contract manufacturing.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Argonaut Manufacturing Services Inc.
- Avioq Inc
- Bio Techne Corp.
- CorDx
- Genemed Biotechnologies Inc.
- HDA Technology Inc.
- HU Group Holdings Inc.
- Invetech
- Jena Bioscience GmbH
- JSR Corp.
- Merck KGaA
- More Diagnostics Inc.
- Neogen Corp.
- PHC Holdings Corp.
- Prestige Diagnostics UK Ltd.
- Seyonic SA
- TCS Biosciences Ltd.
- TE Connectivity Ltd.
- Thermo Fisher Scientific Inc.
- Veracyte Inc.